Company intelligence / Profile preview

Vidafy

Ownership: Private
Development stage: Commercial

Overview

Vidafy markets science-backed nutraceutical products using patented BioMS® nanotechnology to enhance the bioavailability of natural compounds like curcumin. Their products claim to support general health and address chronic inflammation with no reported side effects. Products are manufactured in Germany under GMP certification with Kosher and Halal approvals.

Therapeutic areas: OtherMetabolic DisordersImmunologyNeurology
Modalities: NanoparticleSmall molecule (natural compounds, e.g., curcumin)Nutraceuticals
Industry: Food & Nutrition

Drug pipeline

3 assets

Nanofy

Commercial

Indications: General wellness

2 more assets in the full pipeline.

Request access →

Partnerships

Partner laboratory in Germany for manufacturing and R&DCollaboration with Hohenheim University in Germany; ties to UCLA California as part of scientific network

Beyond the preview

Go deeper on Vidafy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vidafy.

Explore the full profile